Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C19orf70 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
mRNA | RNLS | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | NAA16 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | ATP6V0E2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | ZNF678 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | IGF2R | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | IKZF4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | LUC7L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | MATN2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | ARL2BP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |